Atlas FDA

MITROFLOW AORTIC PERICARDIAL HEART VALVE (MAPHV)

FDA premarket approval P060038/S024 · decided 2015-11-24

Approval details

PMA number
P060038
Supplement
S024
Supplement type
Real-Time Process
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
MITROFLOW AORTIC PERICARDIAL HEART VALVE (MAPHV)
Generic name
heart-valve, non-allograft tissue
Applicant
Corcym Canada Corp
Date received
2015-09-22
Decision date
2015-11-24
Days to decision
63 days
Decision code
APPR
Product code
LWR
Advisory committee
Cardiovascular
Expedited review
No
Location
Burnaby
Statement
APPROVAL FOR REVISIONS TO THE MRI SAFETY LABELING.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.